WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia: Braveheart Bio seeks $319M in US IPO backed by a16z — Warptech Lab News

Storia in 1 fonti

Braveheart Bio seeks $319M in US IPO backed by a16z

Braveheart Bio files for a $319M Nasdaq IPO backed by a16z Bio + Health, raising questions about how crypto's biggest VC allocates risk capital.

Raccontata da

cryptobriefing.com

Timeline cronologica

giovedì 30 luglio 2026·cryptobriefing.com
Braveheart Bio seeks $319M in US IPO backed by a16z
Braveheart Bio files for a $319M Nasdaq IPO backed by a16z Bio + Health, raising questions about how crypto's biggest VC allocates risk capital.
giovedì 30 luglio 2026·cryptobriefing.com
Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm's expanding appetite beyond crypto
Braveheart Bio files for a $318.8M IPO on Nasdaq backed by a16z Bio + Health, targeting a $1.2B valuation for its heart drug candidate BHB-1893.